Uncategorized
Nicox, Ora enter into licensing agreement for AC-120 for morning eyelid swelling
Nicox has entered into a licensing agreement that grants Ora exclusive worldwide rights for the development and commercialization of Nicox’s AC-120 for the treatment of morning eyelid swelling, according to a press release. Under the terms of the agreement, Ora will be responsible for development activities and funding of the program through its investment arm.